# UNIVERSITY OF KENTUCKY: Effects of the Orexin Dual Receptor Antagonist Suvorexant on Cannabis Withdrawal and Self-Administration: a Controlled Inpatient Human Laboratory Study in People with Cannabis Use Disorder

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | UNIVERSITY OF KENTUCKY |
| Location | LEXINGTON, KY |
| Project | Effects of the Orexin Dual Receptor Antagonist Suvorexant on Cannabis Withdrawal and Self-Administration: a Controlled Inpatient Human Laboratory Study in People with Cannabis Use Disorder |
| Project number | 1R01DA065557-01 |
| Mechanism | R01 |
| Institute | National Institute on Drug Abuse |
| Award | $611,927 |
| Awarded | 2026-09-11 |
| Project period | 2026-09-15 to 2031-06-30 |
| UEI | H1HYA8Z1NTM5 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11337805). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.